DHL and Merck Sharp & Dohme Team Up to Enhance Delivery of MECTIZAN to the Developing World
Leaders in Air Express Delivery and Pharmaceutical Innovation Collaborate on Program to Treat River Blindness and Lymphatic Filariasis
Paris, 25 July 2005
DHL and Merck Sharp & Dohme (MSD) today announced that they have signed an agreement to enhance the delivery of MSD's medicine MECTIZAN (ivermectin) to patients affected by the diseases river blindness (onchocerciasis) and lymphatic filariasis (elephantiasis) in Africa, Latin America and the Middle East.
Under the new arrangement, DHL will offer at-cost shipping of MECTIZAN from MSD's facility in Clermont-Ferrand, France to endemic countries through DHL's reliable air express services. The new agreement builds upon an existing relationship between DHL and MSD and combines the core capabilities of the two companies to ensure rapid and flexible delivery of the drug.
